T he concept of frailty has been developed in geriatrics during past decades 1 to define a state of vulnerability and loss of adaptation to stress. [2] [3] [4] Different models 1 have been used to explain the development of frailty. Fried and colleagues, considering frailty as a biological syndrome, suggested the occurrence of a pathophysiological "cycle of frailty associated with declining energetics and reserve" 2 and proposed an operational definition for a frailty phenotype that relies on five criteria: slowness, weakness, weight loss, low level of physical activity, and self-reported exhaustion.
2 Individuals with at least three of the five criteria are classified as frail, and those fulfilling one or two criteria are considered prefrail or intermediate. The frailty phenotype independently predicts recurrent falls, 5 disability, 2, 6, 7 hip fracture, 5, 6 hospitalization, 2 nursing home admission, 7 and death. 2, [5] [6] [7] [8] [9] Nevertheless, many gaps remain in the understanding of the physiopathology of frailty. Although the risk of adverse outcomes seems to increase gradually from the state of nonfrailty to prefrailty and frailty, 2 little is known about the significance of prefrailty. This intermediate stage may provide insights into the mechanisms involved. The stage of prefrailty also deserves special interest because frailty is a continuous process that may be partly reversible, especially in its initial phases. 10 Whereas the association between cardiovascular disease and frailty has been demonstrated, 11, 12 the current study aimed to identify which frailty criteria were more specifically linked with cardiovascular disease. Likewise, although the association between other chronic diseases (e.g., arthritis, diabetes mellitus, chronic obstructive pulmonary disease) and frailty has been established, 2, [13] [14] [15] it was hypothesized that specific chronic diseases might be more tightly linked with one or another frailty criterion. These associations might be involved in different parts of the frailty cycle and could provide indications regarding the physiopathology of frailty.
In this report, it was hypothesized that prefrailty would not be rare in the community-dwelling population aged 65 to 70; the prevalence of chronic diseases and disability would differ significantly between prefrail and nonfrail populations; and the distribution of chronic diseases and disability would differ between individuals with different frailty criteria, even among prefrail individuals experiencing a single frailty criterion. To test these hypotheses, the data from the population-based Lausanne cohort Lc65+ were analyzed. 16 
METHODS

Design
The Lausanne cohort Lc65+ is a longitudinal, observational study started in 2004 at the University of Lausanne Hospital Center (Switzerland). 16 It aims to investigate the determinants, manifestations, and outcomes of frailty from its earliest stage in the general population. A sample of 1,564 individuals representative of the general community-dwelling population has been enrolled and is currently being followed from age 65 to death. The ethics committee of the Faculty of Biology and Medicine of the University of Lausanne has approved the study protocol.
Recruitment Process and Inclusion Criteria
Individuals were enrolled at the age of 65 to 70 and provided written informed consent to participate. 16 To be included in 2004, participants had to be residents of Lausanne (city of 125,000 inhabitants) born between 1934 and 1938. Exclusion criteria at enrollment were being institutionalized or unable to respond because of advanced dementia. Enrollment has been previously described. 16 Of the 3,056 people who were initially mailed questionnaires, 2,096 (69%) replied, of whom 1,564 (75%) agreed to participate. 16 Overall, nonparticipants had demographic characteristics similar to those of participants; 16 only 8% of those refusing to participate attributed their refusal to poor health, 16 and 58% had "a general reluctance to participate in any survey." Of the 1,564 respondents to the initial questionnaire, 1,524 (97.4%) were still eligible, 16 and 1,422 (93.3%) participated in the baseline assessment in 2005.
The present analysis, which focused on prefrailty, included all participants with complete data for frailty classification (nonfrail, prefrail, or frail; n = 1,283).
Assessment Process
Baseline data were collected in 2004 using a self-administered questionnaire sent to participants' homes, followed by an interview at the study center with measurements and performance tests conducted by trained medical assistants in 2005. The questionnaire included items used in the Swiss health surveys, Monitoring of Trends and Determinants in Cardiovascular Disease 17 and the Survey of Health, Aging and Retirement in Europe (SHARE). 18 Items on selfreported medical diagnoses of diseases ("Has a doctor ever told you that you had…?") assessed coronary heart disease (CHD), other heart diseases, stroke, diabetes mellitus, hypertension, chronic respiratory disease, osteoporosis, arthritis, cancer, gastrointestinal ulcer, depression, and hypercholesterolemia. In accordance with the lists of medical diagnoses used in SHARE 19, 20 and the Cardiovascular Health Study (CHS), 2 only eight of these diagnoses were included in the variable "number of chronic diseases": CHD, other heart diseases, stroke, diabetes mellitus, hypertension, chronic respiratory disease, arthritis, and cancer.
Disability in basic or instrumental activities of daily living (ADLs or IADLs) was assessed according to two questions: "During the last four weeks, did you have difficulty with performing the following activities: taking a shower or a bath, getting dressed, eating, getting in/out of bed or an arm-chair, using the toilets?" (ADLs), and "During the last four weeks, did you have difficulty shopping or performing your usual tasks at home?" (IADLs). There were three possible answers: No, I have had no difficulty at all; I have had difficulties with one or more of these activities, but I didn't get help; and I have received help with one or more of these activities. Participants who had received help were considered to have disability.
Frailty Assessment
The clinical assessment was conducted following a standardized protocol. 16 Frailty was assessed at baseline according to the five dimensions of the phenotype described by Fried, 2 although these dimensions were operationalized with partly different criteria; Table 1 , reproduced from a previous publication about Lc65+, 16 details how frailty characteristics were measured in CHS 2 and in Lc65+. Participants with three to five frailty criteria in Lc65+ were categorized as frail, and those with one or two criteria were categorized as prefrail.
Statistical Analysis
Statistical analyses were performed using Stata 12 software (Stata Corp, College Station, TX). Results were expressed as absolute numbers and percentages. Bivariate comparisons were performed using the chi-square test or Fisher exact test for categorical variables. Multivariate odds ratios (ORs) and 95% confidence intervals (CIs) of the prevalence of self-reported chronic diseases were calculated in participants with zero or one frailty criterion using multivariate logistic regression analysis adjusted for sex and all five frailty criteria.
RESULTS
Characteristics of the Sample
The study sample initially included all participants who participated at baseline in the Lc65+ cohort in 2004/05 and were evaluated for frailty (n = 1,283). Birth years were evenly distributed throughout the 1934-1938 period, and 58.5% of participants were women, closely reflecting proportions observed in this age range in the community-dwelling population of Lausanne. Of the 1,283 participants, 71.1% were classified as nonfrail, 26.4% as prefrail, and 2.5% as frail (Table 2) . No participant had all five criteria of the frailty phenotype. Weakness was the most frequent criterion and was experienced by 14.3% of Lc65+ participants (n = 183), followed by weight loss (n = 115, 9.0%), low activity (n = 88, 6.9%), exhaustion (n = 81, 6.3%), and slowness (n = 43, 3.4%). One-third (34.9%) reported two or more chronic conditions diagnosed by a physician, and 37.5% reported a single chronic condition. Hypertension, hypercholesterolemia, and arthritis were most often reported. Most participants were independent in their daily life; 3.7% had received help during the four previous weeks for IADLs only and an additional 1.6% for ADLs.
Most prefrail participants also had at least one chronic disease; 27.5% of all participants had none of the eight listed chronic diseases: 32.0% of the nonfrail, 17.2% of the prefrail, and 9.4% of the frail (test for trend P < .001, Table 2 ). Of the 1,282 participants with complete data regarding the three health dimensions, 288 (22.5%) had no frailty criterion, no disability, and no chronic disease. Of the 338 prefrail participants with complete data, 57 (16.9%) had no disability and no chronic disease.
Characteristics of Prefrail Individuals
Prefrail participants differed significantly from nonfrail participants in many respects (Table 2) . Prefrail participants were more frequently female and were older. Fewer than 2% of nonfrail participants needed help in IADLs (1.4%) and ADLs (0.2%), more than 10% of prefrail participants did so (IADL, 7.4%; ADLs, 2.9%; P < .001). Prefrail individuals also reported comorbidity ( 2 chronic diseases) more often. Specific health conditions that were more frequently reported in prefrail participants than in nonfrail participants included CHD (P = .04), other heart diseases (P < .001), stroke (P = .01), diabetes mellitus (P < .001), hypertension (P < .001), chronic respiratory diseases (P = .02), osteoporosis (P = .01), arthritis (P < .001), and depression (P < .001).
The proportion of women increased across the three frailty categories (nonfrail, 56.5%; prefrail, 62.8%; frail, 71.9%; test for trend P = .01), as did the proportion of older participants (born in 1934: nonfrail, 16.9%; prefrail, 23.9%; frail, 28.1%; test for trend P < .001).
Across frailty categories, there were increasing trends in the prevalence of disability (test for trend P < .001), comorbidity (test for trend P < .001), CHD (test for trend P < .001), other heart diseases (test for trend P < .001), stroke (test for trend P < .001), diabetes mellitus (test for trend P < .001), hypertension (test for trend P < .001), chronic respiratory disease (test for trend P = .001), osteoporosis (test for trend P = .006), arthritis (test for trend P < .001), and depression (test for trend P < .001; Table 2 ). 
Characteristics of Prefrail Individuals Fulfilling a Single Criterion
When considering the 252 participants with a single frailty criterion, 102 (40.5%) had weakness, 73 (29.0%) had weight loss, 43 (17.1%) had low activity, 29 (11.5%) had exhaustion, and five (2.0%) had slowness. The 102 persons with weakness as the sole frailty criterion differed significantly from nonfrail participants: 66.7% were women (vs 56.5% of nonfrail participants, chi-square P = .048), and they were older than nonfrail participants (P = .01). Individuals experiencing weakness alone needed help with ADLs and IADLs more frequently (6% for IADLs only, 4% for ADLs, P < .001, Table 3 ). They more frequently reported two or more chronic diseases (P < .001). Weakness was significantly associated with CHD (P = .003), other heart diseases (P = .001), diabetes mellitus (P = .04), and arthritis (P = .001). Multivariate logistic regression analysis (adjusted for sex and all five frailty criteria, results not shown in Table 3 , but available upon request) indicated that low grip strength was associated with two to three times greater prevalence of CHD (multivariate OR = 2.9, 95% CI = 1.6-5.3), other heart diseases (multivariate OR = 2.9, 95% CI = 1.5-5.6), diabetes mellitus (multivariate OR = 2.2, 95% CI = 1.2-4.1), and arthritis (multivariate OR = 1.9, 95% CI = 1.2-2.8). The 29 participants with exhaustion as the single frailty criterion reported depression (P = .01) and receiving help with ADLs and IADLs (P = .04) significantly more often than nonfrail participants (multivariate OR for the prevalence of depression = 3.0, 95% CI = 1.3-7.0).
DISCUSSION
In this cross-sectional analysis of the Lc65+ cohort study at baseline, 26% of all participants were prefrail, and 2% were frail. Prefrail individuals had significantly more comorbidity and ADL and IADL disability than nonfrail participants. Weakness was the most frequent frailty criterion, and when present in isolation, it was associated with two to three times greater prevalence of CHD, other heart diseases, diabetes mellitus, and arthritis. Similarly, a ) test compares proportions in the group of nonfrail participants with the group of prefrail participants. a Fisher exact two-tailed test (if expected frequency <5 in any of the cells). b All chronic diseases were self-reported medical diagnoses. The number of chronic diseases included coronary heart disease, other heart diseases, stroke, diabetes mellitus, hypertension, chronic respiratory disease, arthritis, and cancer (maximum number = 8). c Congestive heart failure, cardiac valvular disease, and heart muscle disease. ADL = activity of daily living; IADL = instrumental activity of daily living. significant association was identified between exhaustion and depression. The existence of associations between individual frailty criteria and specific chronic diseases suggests that they could result from common pathophysiological changes. Further exploration of these processes in longitudinal studies may contribute to understanding the natural history of frailty.
Prevalence of Frailty, Disability, and Comorbidity at Baseline
In this "young old" age group (65-70), frailty was uncommon (2%), whereas one-quarter were prefrail. Any attempt to compare prevalence estimates across studies should be conducted with caution, because the definitions of the frailty criteria, the distribution of confounders (e.g., age and sex), and exclusion criteria differ between studies. Prefrailty prevalence in Lc65+ appeared to be lower than in other studies, which reported a prevalence ranging from 43% to 54%. 2, 5, [21] [22] [23] In SHARE, prefrailty prevalence after age 65 ranged from 35% in Germany to 51% in Spain, with a north-south gradient, 18 but these studies included older individuals (mean age from 74 18,21 to 82 5, 22, 23 ). In the estimation of the authors of the current study, the prevalence of prefrailty among CHS participants aged 65 to 74 should have approximated 44%. 2 This sample included older individuals than in Lc65+, as well as a minority cohort of 687 African American men and women (who have higher frailty prevalence), and the frailty criteria measured in CHS 2 and Lc65+ were different. In Lc65+, 48% of prefrail and 78% of frail individuals reported at least two chronic diseases; corresponding percentages in CHS were 54% and 68%, 2 although CHS had a somewhat different list of chronic diseases (validated by clinical tests 2 ) and other exclusion criteria (Parkinson's disease; Mini-Mental State Examination score less than 18; use of carbidopa-levodopa, donepezil, or antidepressants). In a Taiwanese health survey of elderly adults, 15 76% of prefrail and 85% of frail individuals had two or more selfreported chronic diseases, although the definition of chronic disease was broader, including osteoporosis and cataracts. Disability prevalence (basic or instrumental) appeared to be lower in Lc65+ prefrail participants (10%) than in CHS (29%), 2 and the prevalence of instrumental All chronic diseases are self-reported medical diagnoses. The number of chronic diseases included coronary heart disease, other heart diseases, stroke, diabetes mellitus, hypertension, chronic respiratory disease, arthritis, and cancer (maximum number = 8). c Congestive heart failure, cardiac valvular disease, and heart muscle disease. ADL = activity of daily living; IADL = instrumental activity of daily living.
disability in Lc65+ (7%) seemed to be lower than in the Osteoporotic Fractures in Men Study 8 (MrOS, 20%) or the MOBILIZE Boston Study 24 (28%), although disability was defined more strictly in Lc65+ (having received help with ADLs in the past 4 weeks) than in CHS 2 or MOBI-LIZE 24 (difficulty in 1 ADLs). CHS 2 and MOBILIZE 24 also included older participants. Increasing trends in the prevalence of comorbidity and disability across frailty categories confirm previous results.
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The
Most Frequent Frailty Criterion in Prefrail Participants
In Lc65+, the most frequent frailty criterion (alone and in association with other criteria) was weakness, followed by shrinking, low activity, exhaustion, and slowness. Weakness prevalence appeared lower in Lc65+ (14%) than in the 10 countries of SHARE (26%) but similar to Switzerland alone (17%). 18 Despite the younger age of Lc65+ participants, weakness prevalence seemed slightly higher in Lc65+ participants than in the men of MrOS (13%), 8 possibly because weakness is more frequent in women 25 (a finding also observed in Lc65+). Shrinking seemed slightly more prevalent in Lc65+ (any unintentional weight loss over the past year, 9%) than in MOBILIZE (7%) 24 or the Hertfordshire Cohort Study (4-5%), 25 but these studies defined shrinking as a weight loss of more than 10 pounds during the past year. The prevalence of exhaustion (determined with slightly different sentences) appeared to be similar in Lc65+ (6%), MOBILIZE (9%), 24 the Hertfordshire Cohort Study (6% in men, 10% in women), 25 and MrOS (8%). 8 Slowness was present in 3% of Lc65+ participants, 3% of MrOS participants, 8 and 8% of the participants in a German study on prefrail individuals 26 that included institutionalized participants and had differing exclusion criteria.
Although several articles have identified the most frequent criterion in specific age groups, 2, 8, 18, 24, 26 to the knowledge of the authors of the current study, not many studies have identified the first frailty criterion. In the Women's Health and Aging Study II (WHAS II), 27 a longitudinal study with a 7.5-year follow-up period that included 420 nonfrail women aged 70 to 79 at baseline, weakness was the most common initial manifestation. Although weakness had the highest prevalence in Lc65+, the crosssectional design of the present report precludes the conclusion that it is the first criterion to appear. This hypothesis must be evaluated in the follow-up data. Grip strength has already been identified as a powerful independent predictor of disability 28 and of cause-specific and total mortality.
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The Chronic Diseases Most Frequently Associated with Prefrailty in Lc65+
Prefrail Lc65+ participants had a significantly higher prevalence of CHD, other heart diseases, stroke, diabetes mellitus, hypertension, chronic respiratory disease, osteoporosis, arthritis, and depression than nonfrail individuals, findings also observed in CHS 2 and WHAS II. 27 As in CHS 2 and WHAS II, 27 prefrail participants had a significantly higher prevalence of disability than nonfrail participants.
Previous studies have reported associations between chronic diseases 2, 12, 26, 27, 30 and prefrailty but not with individual frailty criteria. In Lc65+, low grip strength was associated with a significantly greater prevalence of CHD, other heart diseases, diabetes mellitus, and arthritis. The link between frailty and mortality has often been described as being mediated through the cardiovascular system (subclinical disease). 12 Of the pathways suggested to explain this association, atherosclerosis, a state of chronic inflammation resulting in a loss of lean mass (among other consequences), has been proposed. 12 The association between low grip strength and cardiovascular diseases observed in Lc65+ is consistent with this hypothesis. In addition, the association between diabetes mellitus and low grip strength has long been reported, 31 and individuals with diabetes mellitus develop the conditions necessary for frailty earlier than other individuals as they age. 13 Exhaustion as a single frailty criterion was significantly associated with depression, an association previously observed. 26 A Taiwanese survey also reported a high prevalence of depressive symptoms in frail (89%) and prefrail (32%) elderly adults. 15 In Lc65+, 19% of prefrail participants reported depression (vs 11% of nonfrail participants, P < .001). Although the cause of its association with frailty remains unknown, depression has a recognized prognostic value. 32 These cross-sectional associations between individual frailty criteria and distinct chronic diseases deserve additional study in longitudinal analyses. Arthritis may be a local and straightforward explanation for weakness, and this frailty criterion may not be specific. The independent prognostic significance of weakness as a sole frailty criterion should be evaluated before weakness alone can be considered a target for prevention.
Limitations
Of all 3,056 individuals contacted, 1,422 (47%) completed the baseline assessment. This final participation rate was comparable with other surveys involving communitydwelling individuals (rather than hospitalized persons) in Western countries; [33] [34] [35] for example, in CHS, 33 31% of those contacted in the randomly selected sample were enrolled. Studies looking for systematic differences in health status between participants and nonparticipants yielded inconsistent results. 34, [36] [37] [38] The nonparticipation rate seems to be higher in lower socioeconomic groups. 38 There might have been a selection bias due to differential participation rates across frailty categories in Lc65+, although only 8% of those refusing to participate attributed their refusal to poor health. 16 The prevalence of frailty, comorbidity, and disability may have been underestimated if affected individuals had lower participation rates than healthy persons, which could affect the generalizability of the findings.
Although Lc65+ frailty criteria differed partly from the criteria that Fried and colleagues proposed, 2 different operationalizations of the phenotype's dimensions reflect the same underlying mechanisms (e.g., weight loss, sarcopenia, and diminution of the reserve capacity). The consistency of observations across diverse studies with various measurement instruments supports the plausibility of the findings. These limitations (e.g., potential selection bias and different definitions of frailty criteria) might have affected prevalence estimates for prefrailty but are unlikely to explain the existence of associations between individual frailty criteria and specific chronic diseases. Weakness was involved in most of the associations observed in Lc65+, and it was measured using Fried's exact definition.
Assessment of comorbidity was based on self-reporting of medical diagnoses. Self-reported diseases are often used in population-based studies 15, 19, 20 and seem to be accurate [39] [40] [41] for specific diagnoses. Studies have observed substantial [41] [42] [43] agreement between self-reporting and medical reporting of medical conditions, particularly for lifethreatening, acute-onset diseases (e.g., myocardial infarction and stroke) and chronic symptomatic disorders requiring ongoing management (e.g., diabetes mellitus). 39, 44, 45 Participants usually underreport hypertension, 45 and agreement on heart failure differs between studies. 40, 43 When compared with general practitioners' information, the accuracy of patient self-reporting is substantial for cancer but poor for arthritis. 39 Nonetheless, errors in disease measurement due to self-reporting are unlikely to have a differential distribution across frailty categories; underreporting of some conditions should have led to nondifferential misclassification, attenuating the strength of associations between isolated frailty criteria and specific diseases.
Strengths
Unlike other studies, 2, [21] [22] [23] this study population had a narrow age range (65-70), which limits the potential for age-related confounders or biases, such as selection bias due to differential participation rates across age groups. 33 Except for institutionalization and advanced dementia, this study did not exclude individuals with specific diseases, whereas other studies excluded persons with terminal cancer, 15 arthritis, angina pectoris, chronic obstructive pulmonary disease, or depression 26 or those taking antidepressants. 2 The design of the current study allowed associations between individual frailty criteria and chronic diseases to be examined. Furthermore, the limited number of exclusion criteria led to a study sample that was more representative of the source population.
CONCLUSION
Frailty is rare in the youngest old, whereas prefrailty is common. Weakness is the most frequent frailty criterion; when present in isolation, it is significantly associated with CHD, other heart diseases, diabetes mellitus, and arthritis. Likewise, exhaustion is associated with depression. Longitudinal studies regarding the evolution of prefrail persons should explore the role of potential interactions between individual frailty criteria and specific chronic diseases.
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